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ABSTRACT
Physical disruption of cellular membranes arising from interactions with
engineered nanoparticles is an important, but poorly understood aspect of
nanotoxicology and nanomedicine. Model cellular membranes (i.e. lipid bilayers) can
be used to identify interaction mechanisms, and most studies have largely focused on
lipid bilayers supported on solid planar or spherical substrates. While useful and
informative, these systems do not accurately represent an intact cell membrane because
they restrict the elastic motion of the bilayer and the capacity for mechanical changes.
Free standing bilayers are preferred, but add complexity. Given the importance of
nanoparticle–membrane interactions in nanotoxicology and nanomedicine, and the vast
range in nanoparticle composition, size, shape, and surface functionalization, there is a
need to develop techniques that can rapidly and inexpensively analyze the membranenanoparticle activity by using free standing or unsupported membranes.
This work develops a centrifugation-based assay that can analyze the
membrane- nanoparticle activity as a function of nanoparticle surface functionalization,
membrane lipid composition, and monovalent salt concentration (NaCl). Free standing,
unsupported vesicles were used to gain relevant information on elastic membrane
deformation and vesicle destabilization due to nanoparticle binding. Silver
nanoparticles were chosen due to their widespread biological applications and surface
plasmon resonance (SPR) properties. UV-vis based centrifugation assay, coupled with
cryo-TEM and DLS analysis, was proposed to screen nanoparticle-membrane
interactions; silver nanoparticles binding ratio RSPR was calculated as a function of Ag
nanoparticle coating and vesicle composition. Study showed that strong electrostatic

attraction led to significant sedimentation, vesicle / membrane disruption and higher
RSPR value; in contrast, systems that exhibited weak or no electrostatic attraction did not
show significant sedimentation, membrane disruption or high RSPR value. The
centrifugation assay provides a rapid and straightforward way to screen nanoparticle–
membrane interactions.
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CHAPTER 1

Introduction

1.1 Nanoparticle - membrane interaction
Over the past two decades, nanoparticles have been increasingly used for
biological applications such as antimicrobial agents, therapeutics imaging, diagnosis
and targeted drug / gene delivery.1-33 For example, silver nanoparticles have been used
for disinfection and creating antifouling surfaces.22 Superparamagnetic iron oxide
(SPIO) and gold (Au) nanoparticles have been reported in the field of tumor disgnostics
and cancer treatment.9-10, 16-21 Semiconducting nanocrystals, e.g. quantum dots, were
used to improve biological imaging for medical diagnostics,14 and these crystals were
able to offer resolutions up to 1,000 times better than conventional dyes used in many
biological tests. Furthermore, multifunctional nanoparticles, which have both diagnostic
and therapeutic functions, are able to stimulate gene or drug release at targeted location
when triggered by external stimuli, and minimize the risk to normal tissues.26-30
The introduction of nanoparticles into biological processes leads to new
challenges: (1) the characterization of the interaction between nanoparticles and cell
membranes; (2) the evaluation of biocompatibility between nanoparticles and cell
membranes; (3) the measurement of the cytotoxicity induced by nanoparticles and (4)
the prediction of the impact of nanoparticles to biological systems. It has been observed
that nanoparticles were able to bind to membrane, causing local changes in membrane

1

curvature.34-37 The extent of nanoparticle-induced biophysical and/or biochemical
changes on cell membranes would be dependent on the size, charge, surface reactivity,
surface chemistry and compositions of nanoparticles.38-42 It has been studied that
nanoparticles may introduce carcinogenic risks, which may be triggered by the
production of reactive oxygen species (ROS) by macrophages attempting to destroy
foreign materials on the inflammation sites. The ROS produced in this process, may
cause DNA damage as well as inflammatory lesions associated with carcinogenesis.4344

The broad applications of nanoparticles and their toxicity prompt investigations
not only on their functional mechanisms, but also on their cytotoxicity. The size, charge,
surface chemistry, and compositions of nanoparticles are important parameters for their
physicochemical properties and biological applications. Therefore, there is the urgency
to determine how the size, charge, and surface chemistry of nanoparticles influence their
functional mechanism and their cytotoxicity.45-47 In this study, nanoparticle - membrane
interaction was characterized in order to provide fundamental understanding of the
interaction between nanoparticles and cellular systems, and to provide guidance in the
design and development of safe nanoparticles for biological applications.

1.2 Silver nanoparticle - membrane interaction
In this work, silver nanoparticles (AgNPs) were chosen to study the nanoparticle
membrane interaction due to their widespread biological applications and surface
plasmon resonance (SPR) property. Firstly, silver nanoparticles are important
antimicrobial agents.48-52 AgNPs are able to destroy bacterial cell walls, to trigger
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conformational changes of the ion channel, to cause changes of channel opening and
dysfunctions. Therefore understanding silver nanoparticle - membrane interactions is
essential to understand their toxic effects on both human health and the environment.
Secondly, when silver nanoparticles interact with light, the conduction electrons on the
silver surface oscillates at specific wavelength, giving AgNPs the surface plasmon
resonance (SPR) property.53-54 SPR can be assessed by ultraviolet-visible (UV-vis)
spectroscopy. Its absorbance and wavelength are functions of AgNP concentrations and
aggregation states. Therefore, SPR allows the determination of both AgNP
concentrations in supernatant and sediment phases, and AgNP aggregation states in
solution and after membrane binding.
Experiments were conducted using anionic, cationic and neutral silver
nanoparticles and lipid bilayer vesicles. Unsupported vesicles were used to allow elastic
membrane deformation and vesicle destabilization due to nanoparticle binding.
Supernatant and sediment phases were characterized by cryogenic transmission electron
microscopy (cryo-TEM) to directly image nanoparticle membrane binding and to
connect vesicle stability and structure with the observed centrifugation behavior.

1.3 Specific Research Aim and Hypothesis
Aim: Determine nanoparticle - membrane interactions; quantify electrostatic
interactions as a function of nanoparticle size, surface chemistry and membrane
composition; examine the degree of nanoparticle aggregation at membrane / water
interfaces; and the effects of aggregation on membrane disruption.
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Hypothesis: Nanoparticle - membrane interactions lead to nanoparticle
aggregation at membrane / water interfaces, and cause membrane disruption and pore
formation. These phenomena can be examined by employing a centrifugation-based
assay.

Task 1. Develop a centrifugation-based assay capable of screening
nanoparticle-membrane binding.
Task 2. Determine the extent of nanoparticle aggregation as a function of
nanoparticle-membrane and nanoparticle-nanoparticle interactions
via UV-vis spectroscopy.
Task 3. Examine membrane disruption and destabilization due to
nanoparticle binding and aggregation via cryo-TEM.
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CHAPTER 2

Background

2.1 Cell membranes (vesicles / lipid bilayers)
Membranes are the most common cellular structure in both animals and plants
(Figure 2-1).1-3 Membranes participate almost all aspects of cellular activity, which
ranges from simple mechanical functions such as motility, food entrapments, and
transport, to highly specific biochemical processes such as energy transduction,
immunological recognition, nerve conduction and biosynthesis.
Lipids are major components of all cell membranes. Most biological lipids are
phospholipids or glycolipids that generally consist of hydrophilic heads and
hydrophobic tails (Figure 2-1). When lipids contact with water, ‘heads’ are attracted to
water, while the hydrophobic acyl ‘tails’ are repelled by water, forming lipid bilayer
shells that are 4 - 5 nm thick with an aqueous core.1-3 Other than protecting the cell, the
lipid bilayer is able to compartmentalize different regions on a cell membrane.
Antibodies, protein receptors, and other biosensor molecules that are attached to the
lipid bilayers are able to accommodate enzymes, proteins, DNA, and various drug
molecules. Simply, lipids act as a solvent for all the substances, facilitating their
diffusion through the membrane.
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A

B

C

Figure 2-1 (A) Cell structure and cell membrane (wikipedia). (B)

Schematic depicting lipid bilayer (also called vesicles). (C) A single
lipid structure.

Vesicles are artificially formed capsules of phospholipid bilayers, and able to store
and carry hydrophobic molecules to move within their bilayer, or hydrophilic molecules
in their inner shell, which forms a very flexible carrier systems. It is frequent to find
vesicles in cosmetic and pharmaceutical formulations.2 Vesicles serve as model systems
for experimental and theoretical studies on the characterization of the interaction
between nanoparticles and cell membrane.

11

Table 2-1. Membrane lipids used in this study.
Acyl tail

Tm (oC)a

1,2-dipalmitoyl-sn-glycero-3phosphocholine (DPPC)

16:0

41

1,2-dipalmitoylphospho-rac-1-g-snglycero-3-lycerol (sodium salt) (DPPG)

16:0

41

1,2-dipalmitoyl-3-trimethylammoniumpropane (chloride salt) (DPTAP)

16:0

41

Lipid

a

Lipid gel to fluid main phase transition or melting temperature.

Phospholipid bilayers in vesicles exhibit a sharp phase transition at specified
temperatures,1-3 which is a very important characteristics in their molecular
organization. During the phase transition, a solid ordered phase transforms to a hightemperature liquid-disorder phase. The phase transition is attributed to the melting of
their hydrocarbon acyl chains. Below the chain melting temperature (Tm), the
hydrocarbon chains of phospholipid molecules are tightly bounded together by the van
der Waals forces, and the vesicles exist in a solid state-like gel phase, leading to the
appearance of characteristic angular shapes in vesicles. On the other hand, at
temperatures above Tm, the hydrocarbon chains of phospholipid molecules exhibit
lateral as well as inter-layer mobility, and the vesicles exist in a fluid phase. The phase
transition temperatures of lipids used in this study are listed in Table 2-1.
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2.2 Experimental techniques
For the biomedical applications of nanoparticles, it is necessary to understand
cell membrane-nanoparticle interactions and to assess the safety of nanomaterials.
membrane-nanoparticle interaction studies are complicated 4-13 by (1) the considerable
variation in types of nanoparticles, NP surface functionalization, physicochemical
parameters of the nanoparticles (size, charge, shape and surface area) and nanoparticle
concentration; (2) the lipid composition and the types of assay used; (3) unconfirmed
scientific basis for cytotoxicity; and (4) the lack of characterization techniques.
Therefore, a variety of experimental techniques has been used to understand the
interaction mechanism and the nanoparticle-induced cytotoxicity to guide the design of
biocompatible nanomaterials.
Differential scanning calorimetry (DSC) is capable of capturing the phase
transition behaviors of vesicles such as the transition temperatures (Tm), Tm shifts, and
DSC curve shape changes when vesicles interact with nanoparticles. For example,
during their interactions with cell membranes, superparamagnetic iron oxide (SPIO)
nanoparticles at 30 nm show more significant Tm shifts compared to SPIO at 16 nm.14
A decrease of Tm and a broadening of the transition were observed on supported bilayers
which were formed on the 100 nm silica beads.15
Atomic force microscopy (AFM) was developed to quantitatively measure the
binding force of nanoparticles with cell membranes and to study the morphological
changes of the membranes due to their interaction with nanoparticles. For example,
through AFM studies, it was found that electrostatic interaction drives the binding of
nanoparticles to membranes which causes membrane disruption.16-17 AFM study by
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Roiter et al.18 indicated that nanoscale pores were formed on the lipid bilayer when the
diameter of nanoparticle was smaller than 22 nm. Furthermore, nanoparticles would be
enveloped by the lipid bilayers when the diameter was larger than 22 nm.
Quartz crystal microbalance with dissipation (QCM-D) has been a popular
method recently because it is sensitive to frequency changes (Δf) and energy dissipation
(ΔD) when nanoparticles bind to membrane.19-22 Inductively coupled plasma optical
emission spectrometry (ICP-OES) or mass spectrometry (MS) has also been used, for
example, to probe the interaction between functionalized Au nanoparticles and silica
sphere-supported lipid membranes (SSLMs) by measuring the concentrations of Au
nanoparticles both in the aqueous electrolytes (supernatant) and in/on the lipid
bilayers.23
The

electrophysiological

approach24

coupled

with

the

droplet-in-oil

methodology has been employed to study the interaction between nanoparticles and cell
membranes. In the report by De Palnque et al., the droplet-in-oil methodology was first
used to create lipid bilayers through the self-assembly of two water droplets coated with
a lipid monolayer at water-oil interface. Subsequently, it was found that when silica
nanospheres covered as low as 0.02% of the surface of the bilayers, the
electrophysiological approach was able to detect bilayer current change caused by
nanoparticle adsorption to lipid bilayers. Another electrical approach25 quantified
nanoparticle adsorption to membrane by detecting capacitive increase of suspended
planar lipid bilayers.
In addition, in recent years, computer simulation is gaining increasing attention
for the study of nanoparticle-membrane interactions.26-30 These studies have also
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provided critical information on the relationships between the interactions and the
composition, geometry, and physicochemical properties of the nanoparticles.

2.3 Centrifugation-based assays
For decades researchers have utilized centrifugation-based assays to determine
protein membrane affinity or binding, where the amount of bound protein can be
determined by a mass balance taking into account the supernatant (free protein) and
sediment (membrane-bound protein) phases.31 Centrifugation methods to assay proteinmembrane binding affinity have proven to be simple and inexpensive techniques.
Proteins are one of nature's nanoparticles, and the objective of this work is to test the
applicability of a centrifugation-based assay for quantifying physical nanoparticlemembrane interactions in model bacterial membranes and to examine electrostatic
interactions as a function of nanoparticle size and surface chemistry and membrane
composition, and to determine how local interactions yield global changes in membrane
structure and function.
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3.1 Abstract
Centrifugation-based assays are commonly employed to study protein–membrane
affinity or binding using lipid bilayer vesicles. An analogous assay has been developed
to study nanoparticle–membrane interactions as a function of nanoparticle surface
functionalization, membrane lipid composition, and monovalent salt concentration
(NaCl). Anionic (carboxylic acid, Ag–COOH), cationic (amine, Ag–NH), and
polyethylene glycol coated (Ag–PEG) silver nanoparticles (AgNPs) were examined
based on their surface plasmon resonance (SPR), which was used to determine the
degree of binding to anionic, cationic, and zwitterionic membrane vesicles by analyzing
supernatant and sediment phases. SPR was also used to examine AgNP aggregation in
solution and at membrane–water interfaces, and direct visualization of AgNP–
membrane binding, vesicle aggregation, and vesicle disruption was achieved by
cryogenic transmission electron microscopy (cryo-TEM). The extent of AgNP binding,
based on AgNP + vesicle heteroaggregation, and vesicle disruption was dependent upon
the degree of electrostatic attraction. Because of their biological and environmental
relevance, Ag–PEG + anionic vesicles systems were examined in detail. Cryo-TEM
image analysis was performed to determine apparent membrane–water partition
coefficients and AgNP aggregation states (in solution and bound to membranes) as a
function of NaCl concentration. Despite possessing a PEG coating and exhibiting a
slight negative charge, Ag–PEG was able to bind to model anionic bacterial membranes
either as individual AgNPs (low salt) or as AgNP aggregates (high salt). The
centrifugation assay provides a rapid and straightforward way to screen nanoparticle–
membrane interactions.
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3.2 Introduction
Nanoparticles interact with cell membranes by first binding at the membrane–water
interface. Interfacial interactions and the adhesive binding strength are based on
nanoparticle surface functionalization and membrane lipid composition, and control the
extent to which a nanoparticle will penetrate into the membrane and disrupt lipid
organization and membrane structure.1,2 There is evidence that these nanoparticle–
membrane interactions inhibit cellular function and contribute to nanoparticle toxicity.3–
6

A number of experimental techniques have been used to study nanoparticle

interactions with model cell membranes, which are commonly employed to investigate
binding mechanisms and biophysical changes in membrane structure, including atomic
force microscopy,7–9 fluorescence microscopy,10 quartz crystal microbalance,11–15
differential or isothermal scanning calorimetry,16–19 electrical

capacitance,20 and

cryogenic transmission electron microscopy.15, 21, 22 These studies have provided critical
information that will be needed to develop approaches that can predict nanoparticle–
membrane

interactions

based

on nanoparticle composition,

geometry,

and

physicochemical properties.
Based on the experimental techniques employed, nanoparticle–membrane
interaction studies have largely focused on lipid bilayers supported on solid planar or
spherical substrates (e.g. microparticles23). While very useful and informative, these
systems do not accurately represent an intact cell membrane because they restrict the
elastic motion of the bilayer and the capacity for mechanical changes. Given the
importance

of

nanoparticle–membrane

interactions

in

nanotoxicology

and

nanomedicine, and the vast range in nanoparticle composition, size, shape, and surface
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functionalization, there is a need to develop techniques that can rapidly and
inexpensively analyze the membrane-activity of nanoparticles using free standing or
unsupported membranes. For decades researchers have utilized centrifugation-based
assays to determine protein–membrane affinity or binding, where the amount of bound
protein can be determined by a mass balance taking into account the supernatant (free
protein) and sediment (membrane-bound protein) phases.24 Proteins are one of nature's
nanoparticles, and techniques to examine protein membrane binding are well developed
and may be amenable to nanoparticles.
The objective of this work was to test the applicability of a centrifugation-based
assay for determining nanoparticle–membrane interactions and to examine electrostatic
interactions as a function of nanoparticle and membrane composition. Silver
nanoparticles (AgNPs) were examined based on their widespread biological
applications (e.g. as antimicrobial agents6, 25–28) and relevance to nanotoxicology, and
their surface plasmon resonance (SPR) properties.29, 30 SPR was assessed by ultravioletvisible (UV-vis) spectroscopy, and the SPR absorbance and wavelength were functions
of AgNP concentration and aggregation state. These features were used to determine
AgNP concentrations in supernatant and sediment phases, and AgNP aggregation state
in solution and after membrane binding. Experiments were conducted using anionic,
cationic, and neutral AgNPs and lipid bilayer vesicles as a function of monovalent salt
concentration. Unsupported vesicles were used, as in most protein-based assays, to
allow for elastic membrane deformation and vesicle destabilization due to nanoparticle
binding. Supernatant and sediment phases were characterized by cryogenic transmission
electron microscopy (cryo-TEM) to directly image nanoparticle–membrane binding and
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to connect changes vesicle stability and structure with the observed centrifugation
behavior.

3.3 Materials and methods
3.3.1 Chemicals and materials
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine
dipalmitoyl-sn-glycero

(DPPC,

3-phospho-(10-rac-glycerol)(DPPG,

dipalmitoyl-3-trimethylammoniumpropane

zwitterionic),
anionic),

trimethylammoniumpropane

and

1,21,2-

(DPTAP,

cationic) were purchased from Avanti Polar Lipids (Alabaster, AL). Fig. 3-1A shows
the chemical structures of the lipids. AgNPs dispersed in deionized (DI) water were
purchased from Ocean Nanotech (Springdale, AR). These included AgNPs (referred to
as Ag–PEG) with a monolayer of polyethylene glycol-grafted polyethylenimine (PEI)
coating; anionic AgNPs (referred to as Ag–COOH) with a carboxylic acid
functionalized amphiphilic polymer coating; cationic AgNPs (referred to as Ag–NH)
with a PEI coating (Fig. 3-1C and D). Deionized (DI) ultrafiltered water was obtained
from a Millipore Direct-Q3 UV purification system (Billerica, MA) at 18.2 mΩ
resistance and pH 6.2. Sodium chloride (NaCl, >99.5%) was purchased from Fisher
Scientific (Waltham, MA).
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Fig. 3-1 (A) Lipids used to create vesicular model cell membranes. The group, R, represents
C15H31 acyl tails. (B) Cryo-TEM micrograph of a DPPC/DPPG (3:1) vesicle dispersion. (C)
Ag nanoparticle compositions. All nanoparticles studied contain a surface bound
dodecanethiol layer. Ag–COOH nanoparticles contain an amphiphilic polymer coating.
Ag–NH and Ag–PEG nanoparticles contain an additional PEI or PEG-grafted PEI coating,
respectively. (D) TEM micrograph of Ag–PEG nanoparticles.
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3.3.2 Membrane (vesicle) preparation
Vesicles were prepared at 10 mM total lipid concentration in DI water or NaCl
solutions (10 mM or 100 mM). Lipids, dissolved in chloroform, and water were added
to a round-bottom flask, vortexed for 1 min, and then subjected to rotary evaporation at
50 0C to remove chloroform. After the chloroform was removed, the flask containing
vesicles was transferred to a bath sonicator at 50 0C and sonicated for 30 min. The
vesicles were sized by extrusion through double-stacked polycarbonate membranes with
100 nm pore diameters. Neutral membranes were prepared using DPPC and anionic or
cationic membranes were prepared using mixtures of DPPC with DPPG or DPTAP at
3 : 1 or 1 : 1 molar ratios, respectively. A representative cryo TEM images of
DPPC/DPPG vesicles is shown in Fig. 3-1B.

3.3.3 Cryogenic transmission electron microscopy
Vitrification of sample specimens for cryo-TEM was performed using a Vitrobot
(FEI Company), which is a robotic preparation system with controlled temperature and
humidity. Specimens were prepared on Quantifoil grids with 2 mm holey-carbon on 200
square mesh copper (Electron Microscopy Sciences, Hat-field, PA). After the sample
was equilibrated within the Vitrobot at 25 oC and 100% humidity for 30 min, the grid
was plunged into the sample, withdrawn, and blotted to yield a thin specimen film. The
specimen was then vitrified by plunging the grid into liquid ethane, and transferred to
liquid nitrogen. Imaging was performed in a cooled stage (model 915, Gatan Inc.,
Pleasanton, CA) using a JEOL JEM-2100F TEM (Peabody, MA). Image analysis was
performed using Image J software.
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3.3.4 Dynamic light scattering and zeta potential
Dynamic light scattering (DLS) and zeta potential (z) measurements were
performed using a Malvern Zetasizer Nano ZS (Worcestershire, UK) equipped with a
backscattering detector angle of 173 and a 4 mW, 633 nm He–Ne laser. Hydrodynamic
diameters (dh) were measured using optical grade polystyrene cuvettes. Results are
reported as intensity-weighted z-averages based on 15 consecutive scans. Zeta potential
was determined by combined Doppler electrophoretic velocimetry and phase analysis
light scattering using folded capillary cells. Zeta potential was computed over 3 cycles
(30 data points per cycle) using the Smoluchowski equation.

3.3.5 UV-vis spectroscopy
UV-vis spectroscopy was conducted using an Agilent Cary 50 (Santa Clara, CA)
spectrophotometer with a Peltier cuvette holder for temperature control. Samples were
equilibrated at 25 oC for 3 min in quartz cuvettes (10 mm path length) capped with PTFE
lids. Absorbance spectra were conducted in triplicate and the SPR peak height, peak
area, and peak position (wavelength) of each spectrum was analyzed by OriginPro
software (version 9.0).

3.3.6 Centrifugation assay
A schematic of the UV-vis centrifugation assay is given in Fig. 3-2. Vesicles (4
mM) and AgNPs (10, 50, and 100 mg mL-1) were combined in 1 mL samples,
magnetically stirred for 3 min, and then kept 25 oC for 1 h. UV-vis analysis of SPR was
conducted on this sample before centrifugation (Fig. 3-2B, solid line 1). The samples
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were then transferred to 1.5 mL centrifuge tubes and centrifuged at 6000g for 15 min
(Megafuge 16R, Thermo Scientific, Asheville, NC). After centrifugation the sample
supernatants, which accounted for approximately 90% of the sample volume, were
withdrawn by pipetting and the SPR analyzed by UV-vis (Fig. 3-2B, dash line 2).
Supernatant and sediment samples were then analyzed by cryo-TEM. All samples were
conducted in triplicate and standard deviations are reported.
Centrifugation conditions were selected after analyzing the sedimentation
behavior of the vesicles and AgNPs. The goal was to determine the centrifugation force
and time that would not cause vesicle sedimentation, but would lead to the
sedimentation of vesicles with bound AgNPs. At 6000g and 15 min vesicles did not
sediment consistent with a calculated settling velocity of ~3 x 10-4 cm min-1 for a 100
nm diameter vesicle based on Stoke's law, which assumes that the vesicles do not
interact. However, at this centrifugation condition all three AgNPs exhibited the first
signs of sedimentation, and little difference in AgNP sedimentation was observed
between DI water and salt solutions (Table S1†).
AgNP binding was inferred based on mass balance obtained by UV-vis analysis
of the SPR where SPR peak area was a linear function of AgNP concentration. Apparent
AgNP binding was determined as the ratio RSPR

𝑅𝑆𝑃𝑅 =

Where ∆ASPR,

NPs+vesicles

∆𝐴𝑆𝑃𝑅,𝑁𝑃𝑠+𝑣𝑒𝑠𝑖𝑐𝑙𝑒𝑠
∆𝐴𝑆𝑃𝑅,𝑁𝑃𝑠

(1)

was the change in the SPR peak area for AgNPs + vesicles

before and after centrifugation, and ∆ASPR,
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NPs

was the change for AgNPs. This

approach takes into account the inherent sedimentation behavior of the AgNPs. RSPR =
1 indicated that there was no difference in sedimentation relative to the AgNPs alone.

Fig. 3-2 (A) Schematic depicting centrifugation of nanoparticles + vesicles (NP + V) and
the boundary between supernatant and sediment phases. (B) Exemplary UV-vis spectra
of the AgNP SPR of the supernatant phases before and after centrifugation.
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3.4 Result and discussion
3.4.1 Characterization of vesicles and AgNPs
The hydrodynamic diameters and zeta potentials of the AgNPs and vesicles
employed are summarized in Tables 3-1 and 3-2, respectively. AgNPs exhibited an
average core diameter of 6.4 ± 2.7 nm based on high vacuum TEM analysis and average
hydrodynamic diameters from 10–30 nm (Table 3-1). Difference between core and
hydrodynamic diameters reflect the polymer coatings. Zeta potential analysis, ζNP,
confirmed the slightly anionic nature of Ag–PEG, and the anionic and cationic nature
of Ag–COOH and Ag–NH, respectively. All vesicles exhibited hydrodynamic
diameters (dh) between 95 and 120 nm consistent with membrane extrusion and cryoTEM analysis (Table 3-2 and Fig. 3-1B). Zeta potentials for charged vesicles, ζV,
decreased with increasing NaCl concentration consistent with ion binding and charge
screening. Based on the average vesicle and AgNP core diameters, the AgNP
concentrations examined (10, 50, and 100 µg mL-1) corresponded to approximately 0.4,
2.0 and 4.0 nanoparticles per vesicle (NP : V), respectively, and nanoparticle surface
coverage (on the vesicle exterior) ranging from ~0.1% to 7.5%. These ratios were based
on vesicles with dh = 110 nm and an average lipid headgroup area of 0.5 nm2.31 The
relative strength of the electrostatic attraction or repulsion between vesicles and AgNPs
is presented as the product of the zeta potentials, ζVζNP, which reflects electrical double
layer interactions based on the Poisson–Boltzmann equation (Table 3-2).32
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Table 3-1. AgNP properties.

Core size (nm)
Hydrodynamic diameter (nm)
Zeta potentiala (mV)
SPR peak maximum (nm)
a

Ag-PEG

Ag-COOH

Ag-NH

19
-16
410

6.4 ± 2.7
10
-45
412

30
+57
414

Measured in DI water.

Table 3-2. Vesicle (model membrane) properties as a function of lipid composition
and NaCl concentration.
Vesiclea
DPPC
DPPC/DPPG (3:1)
DPPC/DPPG (1:1)
DPPC/DPTAP (3:1)
DPPC/DPTAP (1:1)
DPPC/DPPG (3:1)
DPPC/DPPG (1:1)
DPPC/DPPG (3:1)
DPPC/DPPG (1:1)
a

NaCl
(mM)

dh
(nm)

0

120
95
95
110
110
110
110
110
110

10
100

PDI

ζV
(mV)

0.241
0.228
0.231
0.195
0.172
0.122
0.152
0.165
0.148

<1
-66
-72
+60
+70
-60
-70
-45
-50

Ag-PEG

ζVζNPb
Ag-COOH

Ag-NH

<-10
+660
+720
-600
-700
+600
+700
+450
+500

<-29
+1914
+2088
-1740
-2030
1740
2030
1305
1450

<+60
-3960
-4320
+3600
+4200
-3600
-4200
-2700
-3000

Lipid ratio shown in parentheses.

b

Product of vesicle and AgNP zeta potentials.

3.4.2 Centrifugation assay
RSPR results for Ag–PEG, Ag–COOH, and Ag–NH vesicle binding are shown in
Fig. 3-3. For zwitterionic DPPC vesicles, the greatest sedimentation was observed with
30

Ag PEG, which exhibited a slight negative charge. Little sedimentation was observed
with Ag–COOH and Ag–NH. For anionic DPPC/DPPG vesicles, AgNP binding was
driven by electrostatic attraction. Ag–PEG and Ag–COOH led to minimal
sedimentation due to electrostatic repulsion, while cationic Ag–NH led to near complete
sedimentation (RSPR > 5) at all NP : V ratios. Increasing the DPPG content within the
vesicles (increasing anionic membrane charge) did not affect the sedimentation
behavior, which indicates that all Ag–NH nanoparticles bound to DPPC/DPPG vesicles
at a 3 : 1 lipid ratio, and that increasing the anionic DPPG concentration did not
increasing AgNP binding. This is consistent with the low NP : V ratios examined. For
cationic DPPC/DPTAP vesicles, like charged Ag–NH exhibited no binding, which is
also consistent with electrostatic repulsion. Anionic Ag–COOH bound completely and
led to near complete sedimentation, analogous to that for DPPC/DPPG with oppositely
charged Ag–NH. Ag–PEG also bound and caused sedimentation due to its slight
negative charge. Sedimentation results from the centrifuge assay correlate with
electrostatic

double

layer

attraction

(Fig.

3-3D).

Results

for

dioleoylphosphatidylcholine / dioleoylphosphatidylglycerol (DOPC/DOPG) vesicles
show that the assay is suitable for fluid phase membranes as well as gel phase
(DPPC/DPPG) membranes (Fig. 3-4).
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Fig. 3-3 Ratio of the SPR absorbance before and after centrifugation, RSPR, for AgNPs
added to (A) DPPC, (B) DPPC/DPPG, and (C) DPPC/DPTAP vesicles in DI water as a
function of the nanoparticle to vesicle ratio, NP : V. RSPR takes into account the
sedimentation behavior of the nanoparticles alone. Vesicles alone did not sediment at the
conditions employed. (D) Correlation between RSPR and AgNP–vesicle electrostatic

attraction represented as ζV ζNP (Table 3-2).
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Fig. 3-4 Ratio of the SPR absorbance before and after centrifugation,
RSPR, for AgNPs added to DOPC/DOPG (3:1) vesicles in DI water as a
function of the nanoparticle to vesicle ratio, NP : V.

DLS measurements were performed on the sample mixtures before and after
centrifugation (Fig. 3-5). Strong AgNP binding increased the vesicle hydrodynamic
diameter from ~100 nm to >300 nm due to heteroaggregation. After centrifugation the
vesicle hydrodynamic diameter within the supernatant returned to ~100 nm, reflecting
unbound or unaggregated vesicles. The DLS spectra for like charged AgNPs and
vesicles showed no change from the original vesicle suspension.
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A

B

Fig. 3-5 Size distribution of vesicles alone, before centrifugation
and after centrifugation. (A) DPPC + Ag-NH, (B) DPPC/DPTAP
(1:1) + Ag-NH in DI water at vesicle ratio, NP : V = 4.0.
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It should be noted that nanoparticles can bind to lipid vesicles without causing
sedimentation. For example, Zhang and Granick33, 34 have shown that bound anionic and
cationic nanoparticles can actually stabilize suspensions of zwitterionic vesicles through
electrostatic interparticle repulsion. Similar observations were reported by Chen et al.21
for small anionic nanoparticles and DPPC/DPTAP vesicles where nanoparticle binding
did not lead to vesicle aggregation. These results were obtained at higher nanoparticle
surface coverage than this work (e.g. ~25+%), but the phenomenon may still be
applicable and could account for some of the anomalous trends in RSPR with AgNP
concentration (e.g. Ag–COOH binding to DPPC/DPTAP (3 : 1) vesicles). Hence, while
RSPR does account for sedimentation due to strong electrostatic attraction, it is not
directly indicative of the extent of nanoparticle binding. As shown in the subsequent
sections, vesicles containing bound AgNPs were observed in the supernatant phase even
when significant sedimentation occurred.
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Fig. 3-6. Cryo-TEM micrographs of (A) DPPC + Ag-PEG, (B) DPPC/DPPG (3:1)

+ Ag-NH, and (C) DPPC/DPTAP (3:1) + Ag-COOH. The NP:V ratio was 3.28.
A1, B1, and C1 denote the supernatants and A2, B2, and C2 denote the sediments.
The scale bars represent 200 nm.

3.4.3 Cryo-TEM analysis
AgNP–vesicle binding, vesicle structure, and aggregate state were examined by
cryo-TEM. The criteria for confirming AgNP binding based on the micrographs was the
colocalization of AgNPs and vesicles, AgNPs adopting membrane curvature, and local
changes in membrane curvature due to AgNP binding. Micrographs of supernatant and
sediment phases are shown in Fig. 3-6 for systems that exhibited the highest binding or
RSPR (Fig. 3-6A, DPPC + Ag–PEG; Fig. 3-6B, DPPC/DPPG + AgNH; Fig. 3-6C,
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DPPC/DPTAP + Ag–COOH). The supernatants are denoted with a 1 and the sediments
with a 2. For DPPC + Ag–PEG, 83 AgNPs were observed in the supernatant with 85%
being bound to vesicle surfaces (A1). AgNPs were bound as individual particles and as
particle aggregates, and there is evidence of vesicle disruption (opened vesicles and
bilayer sheets) due to AgNP binding. These structures were not observed in vesicle
samples without AgNPs. Within the sediment (A2), there are more AgNP aggregates,
vesicle aggregates bridged by AgNPs, and ruptured and deformed vesicles.
AgNP binding and vesicle deformation was more prevalent for oppositely
charged AgNPs and vesicles where all AgNPs were vesicle-bound (no unbound AgNPs
were observed). Cationic Ag–NH bound strongly to anionic DPPC/DPPG (3 : 1),
leaving unbound vesicles in the supernatant (B1) and completely disrupted vesicles
aggregates with bound AgNPs in the sediment (B2). There were some ruptured or
deformed vesicles in the supernatant with bound AgNPs (B1), and these regions show
damage (melting) of the vitrified sample film due to what it is believed to be local
heating of AgNPs by the electron gun. Analysis of this system without centrifugation
shows that changes in vesicle structure were driven by AgNP binding and were not
simply an artifact of centrifugation. Strong binding was also observed between Ag–
COOH and DPPC/DPTAP (3 : 1). Free vesicles and vesicles with bound AgNPs were
observed in the supernatant, while large AgNPs and AgNP aggregates are observed in
the sediment with completely ruptured vesicles that formed bilayer sheets. Vesicle
rupture can be attributed to strong adhesive forces that increase with electrostatic
attraction and cause the membrane to partially wrap around or engulf the particle.35
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Fig. 3-7. Surface plasmon resonance (SPR) of Ag nanoparticles with PEG
(solid lines), COOH (dotted lines), and NH (dashed lines) coatings alone

(black lines) or in the presence of DPPC/DPTAP (3:1) (grey lines). The inset
shows the derivative of absorbance with respect to wavelength with the
horizontal line at dA/dλ = 0. Measurements were taken before centrifugation.

3.4.4 AgNP binding and aggregation
Cryo-TEM results are consistent with those in Fig. 3-3. Oppositely charged
nanoparticles strongly interact with and bind to vesicles, leading to vesicle aggregation
and disruption. There was also evidence that AgNP binding led to nanoparticle
aggregation at the membrane–water interface. Shifts in the SPR, ΔλSPR, which are
sensitive to AgNP size, aggregation state, and surface functionalization, and the
presence of adsorbed molecules,36–39 were examined to investigate this further. Fig. 3-7
demonstrates this analysis for DPPC/DPTAP (3 : 1) vesicles where the SPR for AgNPs
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are compared to AgNP + vesicle mixtures before centrifugation (ΔλSPR = λSPR,

NP+V

-

λSPR, NP). All shifts in SPR were ‘red-shifts’ (Table 3-3) and correlated with electrostatic
AgNP–vesicle attraction (Table 3-2). For DPPC/DPTAP, ΔλSPR was 6.8 nm with Ag–
COOH. No change was observed when like charged Ag NH was examined. Similar
results were observed for DPPC/DPPG (3 : 1). Interestingly, DPPC showed modest peak
shifts with three AgNPs. This may be due to the absence of electrostatic attraction,
leaving short-range van der Waals attraction. The SPR shifts could reflect changes in
surface functionalization due to lipid adsorption. However, based on the observed
aggregation behavior after membrane binding, the ΔλSPR are consistent with
interparticle coupling due to particle clustering or aggregation.37, 40, 41 Red shifts in
ΔλSPR have also observed for small gold nanoparticle aggregates adsorbed on the surface
of larger silica nanoparticles.42

Table 3-3. Shifts in the position of the SPR peak, SPR = SPR, NP+VSPR, NP, as a
function of Ag nanoparticle coating and vesicle composition in DI water.
SPR (nm)
DPPC/DPTAP DPPC/DPPGa
3.6
1.0
6.8
0.6
0.1
2.1
a

Ag-PEG
Ag-COOH
Ag-NH
a

DPPC:DPTAP and DPPC:DPPG ratios of 3:1
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DPPC
1.3
1.6
0.9

3.4.5 Effect of salt concentration
Electrostatic interactions were further probed by varying salt concentration. The
studies focused on anionic DPPC/DPPG (1 : 1), which represents a model bacterial
membrane, Ag–PEG nanoparticles, and monovalent NaCl. Ag–PEG was selected
because PEG coatings are commonly employed in nanomedicine and provide a
protective coating that resists protein adsorption.43–45 In conjunction with centrifugation
results (RSPR, Fig. 3-8A), cryo-TEM micrographs were analyzed (Fig. 3-8B and C) to
determine apparent AgNP membrane–water partition coefficients, K, and to compare
the aggregate number for bound and unbound AgNPs (Fig. 3-8D). K was calculated as
the ratio of bound to unbound AgNPs. This analysis was conducted on supernatant
phases and calculated K and aggregate numbers were based on a minimum of seven
micrographs. Little change in RSPR, K, or aggregation number were observed when NaCl
concentration was increased from 0 to 10 mM, however clear increases were observed
from 10 mM to 100 mM (Fig. 3-8A and D).
Cryo-TEM micrographs depict the effects of salt on K and aggregation number.
At 10mMNaCl small AgNPs are membrane bound with little evidence of AgNP
aggregation in the supernatant. Bound and free AgNP aggregates were observed in the
sediment. Close up images show an aggregate closely associated with the membrane
(B3) and individual AgNPs causing local changes in membrane curvature (B4). At 100
mM, all AgNPs were present as individual or bound aggregates in the supernatant (C1)
and K was ~1, denoting an even distribution of AgNPs between the aqueous phase and
the membrane. Aggregates were also observed bound to vesicles in the sediment (C2)
and significantly distorting the membranes (C3). Ag PEG binding to DPPC/DPPG
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membranes resembles what has been observed for Escherichia coli membranes and
anionic (Daxad 19 coated) AgNPs.27
AgNP aggregation behavior was further examined by ΔλSPR for Ag–PEG and
Ag–NH particles alone (water and salt) and mixed with DPPC/DPPG (1 : 1) vesicles
prior to centrifugation (Table 3-4). Ag–PEG alone exhibited a ΔλSPR of 1.8 nm at 100
mM NaCl. No change was observed in DI water or 10 mM NaCl, consistent with the
results above. In AgNP + vesicle mixtures, Ag–PEG exhibited ΔλSPR in DI water, but
not in salt solution. This suggests that Ag–PEG aggregated at high salt conditions and
bound to membranes in the aggregated state. Ag–PEG aggregation also increased its
sedimentation rate, but this was accounted for in the RSPR calculation. Comparatively,
Ag–NH alone showed no ΔλSPR due to strong electrostatic repulsion. Only when Ag–
NH were added to vesicles did they exhibit a SPR peak shift (ΔλSPR > 2). Unlike Ag–
PEG, aggregation of cationic Ag–NH occurred as a result of binding to anionic
membranes, and was facilitated by charge neutralization.
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Fig. 3-8. (A) RSPR for DPPC/DPPG (1:1) + Ag-PEG as a function of NaCl concentration.
Cryo-TEM micrographs are shown at (B) 10 mM and (C) 100 mM NaCl for the
supernatant (B1, C1) and the sediment (B2-B4, C2-C3) phases. Cryo-TEM analysis was
conducted at a NP:V ratio of 4.0. The scale bars represent 200 nm. (D) Apparent
partitioning coefficients (K) and aggregate numbers of vesicle-bound and unbound AgPEG nanoparticles as a function of NaCl concentration. K and the aggregate numbers
were determined within the supernatants after centrifugation.
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Table 4. Shifts in the position of the SPR peak as a function of Ag nanoparticle
coating and NaCl concentration in DI water.
SPR (nm)
NP
NaCl (mM)
0
10
100
a

a

NP+Vb
Ag-PEG
Ag-NH

Ag-PEG

Ag-NH

< 0.1
< 0.1

< 0.1
< 0.1

1.0
0.1

2.1
2.6

1.8

< 0.1

< 0.1

2.5

SPR = SPR, NP saltSPR, NP DI
SPR = SPR, NP+V saltSPR, NP salt

b

3.4.6 DLVO analysis
Biological forces play important roles in nanoparticle-membrane interaction. In
aqueous solutions, van der Waals (VDW) and double layer electrostatic forces act
together to determine whether an interaction is attractive, repulsive or weakly attractive
at some finite separation. These two forces are known as the two forces of the DerjaguinLandau-Verwey-Overbeek theory (the DLVO theory). Understanding biological forces
helps to reveal the physical basis of the interactions.
AgNP binding to DPPC/DPPG vesicles was analyzed by DLVO theory where
the total interaction energy between an AgNP and a vesicle (V) is the sum of the van
der Waals (VvdW) and electrostatic (Velec) interactions. VvdW was calculated as

𝑉𝑣𝑑𝑤
𝑘𝑇

=

𝐴132
6𝑘𝑇

2 𝑅1 𝑅2

(ℎ2 +2𝑅

1 ℎ+2𝑅2

+
ℎ

2𝑅1 𝑅2
ℎ2 +2𝑅1 ℎ+2𝑅2 ℎ+4𝑅1 𝑅2
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+ 𝐼𝑛

ℎ2 +2𝑅1 ℎ+2𝑅2 ℎ
ℎ2 +2𝑅1 ℎ+2𝑅2 ℎ+4𝑅1 𝑅2

)

(2)

where A132 is the effective Hamaker constant based, R are radii, k is the Boltzmann
constant, T is temperature, and h is the surface separation distance based on dh.
Subscripts 1, 2, and 3 denote the AgNP, vesicle, and water, respectively. A132 was
estimated from the Hamaker constants of the membrane (A11, 8 x 10-20 J), water (A33,
3.7 x 10-20 J), and the AgNP (A22, 7.2 x 10-20 J).

𝐴132 = (𝐴33 0.5 − 𝐴11 0.5 )(𝐴33 0.5 − 𝐴22 0.5 )

(3)

Given that the AgNPs contained a thick polymer coating, A22 for polyethylene
glycol was used.46 Velec was calculated as

𝑉𝑒𝑙𝑒𝑐
𝑘𝑇

=

4𝜋𝜀𝑟 𝜀0 𝛷1 𝛷2
𝑘𝑇

𝑅1 𝑅2

(𝑅

1 + 𝑅2

) 𝐼𝑛 [1 + 𝑒𝑥𝑝(−𝑘ℎ)]

(4)

where εr is the dielectric constant of water, ε0 is the permittivity of free space, Φ
are the surface potentials (taken as ζ in DI water), and k is the inverse Debye length. In
DI water, k was based on the Na+ counterion concentration of DPPG (4 mM), and this
concentration was added to the 10 and 100 mM NaCl solutions (Fig. 3-9).
For DPPC/DPPG + Ag–PEG, an energy barrier exists near h = 0.5 nm due to
electrostatic repulsion. This barrier decreases with increasing NaCl concentration due
to charge screening, consistent with the increasing RSPR observed in Fig. 3-8. While this
barrier did hinder Ag–PEG binding, it did not prevent it based on the cryo-TEM results.
For DPPC/DPPG + Ag–NH, strong electrostatic attraction was observed at all NaCl
concentrations despite charge screening. This analysis explains why there was little
44

change in RSPR with Ag–NH in salt solution.

Fig. 3-9 Interaction potential, expressed as V/kT, between Ag–PEG or Ag–NH
particles and DPPC/DPPG vesicles (1 : 1) as a function of Surface separation
distance. NaCl concentrations and the Debye lengths are shown in the legend.

For 0 mM NaCl, the Na+ counterion concentration (4 mM) associated with DPPG
was used to determine 1/k.
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3.5. Conclusion
A UV-vis based centrifugation assay, coupled with cryo-TEM and DLS
analysis, was introduced as a method for examining nanoparticle–membrane
interactions. In analogous protein–membrane centrifugation assays, one can directly
measure bound and unbound protein concentrations. This is not as straightforward for
the nanoparticle–membrane assay. As opposed to a direct measurement, the
nanoparticle–membrane assay reflects changes in the colloidal stability of a sample due
to heteroaggregation that is dependent upon the degree of nanoparticle–membrane
binding. AgNP + vesicles systems that exhibited strong electrostatic attraction led to
significant sedimentation and vesicle/membrane disruption. In contrast, systems that
exhibited minimal or no electrostatic attraction did not show significant changes in
sedimentation behavior or membrane disruption. This suggests that additional analysis
(e.g. imaging) may be needed in conjunction with this assay when examining weakly
interacting vesicle–nanoparticle systems. Further optimization of the assay, including
centrifugation conditions, vesicle size, nanoparticle concentration, may also improve
the ability to examine such systems.
Collectively, the trends observed for nanoparticle binding and membrane
disruption as a function of nanoparticle surface chemistry and lipid composition are
consistent with previous studies that have demonstrated nanoparticle binding and
deformation in small vesicles,13 giant unilamellar vesicles,6, 40 planar bilayers,4 and lipid
monolayers41; nanoparticle partitioning to supported lipid bilayers;20 and nanoparticle
binding and leakage from vesicles.42 By analyzing shifts in SPR wavelength and
comparing to cryo-TEM micrographs, it was possible to discern different modes of
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modes of AgNP binding; individual AgNP binding followed by aggregation at
membrane/water interfaces due to charge neutralization, or aggregate AgNP binding
due to aggregation in solution caused by charge screening.
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CHAPTER 4

CONCLUSION

This study proposes an easy assay analysis to measure surface plasmon
resonance RSPR binding and predict interactions of silver nanoparticles with vesicles.
RSPR value categorizes three types of binding: oppositely charged particles and vesicles
demonstrate destructive interaction, causing vesicles disrupted or totally destroyed.
Oppositely charged nanoparticles have strong interactions with vesicles, the binding
between nanoparticless and vesicles cause nanoparticle aggregation, and nanoparticle
aggregations with vesicles lead to significant sedimentation; similarly charged particles
and vesicles show very weak or zero binding, in the between that is moderate binding.
Salt concentration does not influence interactions between oppositely charged particles
and vesicles because stronger charge maintain nanoparticle stability, however, salt
plays significant role for moderate binding of Ag-PEG particles with DPPC/DPPG,
higher salt concentration makes nanoparticles aggregate , particles aggregates interact
with the vesicles rather than individual particles; nanoparticle aggregates are capable of
penetrating into the vesicles and inducing local changes in membrane curvature.

Compared to protein-membrane centrifugation assays, nanoparticle-membrane
assays do not allow one to directly quantify the degree of nanoparticle binding or the
membrane/water partition coefficient of the nanoparticle. Rather, the nanoparticlemembrane assay reflects the change in the colloidal stability of the vesicle with
nanoparticle sample due to nanoparticle-membrane binding. Two aspects are clear,
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strong nanoparticle-membrane interactions lead to vesicle aggregation, vesicle
disruption/rupture, and nanoparticle aggregation (due to charge neutralization by
adsorbed lipids) while weak nanoparticle-membrane interactions do not lead to
significant aggregation or vesicle disruption. Centrifugation assisted UV-vis assay
provides an inexpensive, useful and quick technique to screen nanoparticle-membrane
interaction.
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